Stavros Stavrakis to Defibrillators, Implantable
This is a "connection" page, showing publications Stavros Stavrakis has written about Defibrillators, Implantable.
Connection Strength
1.451
-
Implantable Cardioverter Defibrillators for Primary Prevention of Mortality in Patients With Nonischemic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials. J Cardiovasc Electrophysiol. 2017 Jun; 28(6):659-665.
Score: 0.547
-
Defibrillation threshold testing does not predict clinical outcomes during long-term follow-up: a meta-analysis. Pacing Clin Electrophysiol. 2013 Nov; 36(11):1402-8.
Score: 0.422
-
Clinical characteristics and long-term clinical course of patients with Brugada syndrome without previous cardiac arrest: a multiparametric risk stratification approach. Europace. 2019 12 01; 21(12):1911-1918.
Score: 0.164
-
Predictors of Adverse Outcomes in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy: A Meta-Analysis of Observational Studies. Cardiol Rev. 2019 Jul/Aug; 27(4):189-197.
Score: 0.159
-
Impact of Implantable Cardioverter-Defibrillator Interventions on All-Cause Mortality in Heart Failure Patients: A Meta-Analysis. Cardiol Rev. 2019 May/Jun; 27(3):160-166.
Score: 0.158